Abstract
View our latest infographic, which provides updates in the field of neurological conditions, focusing on neuromyelitis optica spectrum disorder (NMOSD) and myasthenia gravis (gMG). These rare autoimmune diseases are detailed with prevalence statistics and primary treatment goals, as well as the common goal of ensuring an early and accurate diagnosis in order to optimise patient outcomes.
Subject
Cardiology and Cardiovascular Medicine
Reference33 articles.
1. Alshekhlee A et al. Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals. Neurology. 2009;72(18):1548-54.
2. 2. Bird SJ. Overview of the treatment of myasthenia gravis. 2023. Available at: https://www.uptodate.com/contents/overview-of-the-treatment-of-myasthenia-gravis. Last accessed: 14 July 2023.
3. 3. Burns TM. The best of both worlds: using patient-reported plus physician-scored measures during the evaluation of myasthenia gravis. Muscle Nerve.
4. 2016;53(1):3-4.
5. 4. Chen J et al. Incidence, mortality, and economic burden of myasthenia gravis in China: a nationwide population-based study. Lancet Reg Health West